A Single-Center, Randomized, Double-Blind, Active- and Placebo-Controlled Crossover Study to Evaluate the Subjective Effects of PTI-801 in Non-Physically Dependent Subjects With a History of Drug Abuse.
Latest Information Update: 13 Apr 2026
At a glance
- Drugs Oxycodone/naltrexone (Primary) ; Oxycodone
- Indications Pain
- Focus Pharmacodynamics
- Sponsors Cassava Sciences; Filana Therapeutics; Pain Therapeutics
Most Recent Events
- 10 Mar 2026 According to Cassava Sciences media release, Cassava Sciences is now called Filana Therapeutics.
- 15 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jan 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.